Wang, Tian-Xiang
Liang, Jun-Yun
Zhang, Cheng
Xiong, Yue
Guan, Kun-Liang http://orcid.org/0000-0003-1892-0174
Yuan, Hai-Xin http://orcid.org/0000-0002-1624-3934
Funding for this research was provided by:
National Natural Science Foundation of China (81773190)
Article History
Received: 20 July 2019
Revised: 30 August 2019
Accepted: 12 September 2019
First Online: 7 October 2019
Conflict of interest
: Kun-Liang Guan is a co-founder of Vivace Therapeutics. Yue Xiong is a co-founder of Cullgen Inc. The remaining authors declare that they have no conflict of interest.